Ventive Hospital

  • Market Cap: Small Cap
  • Industry: Hotels & Resorts
  • ISIN: INE781S01027
  • NSEID: VENTIVE
  • BSEID: 544321
INR
579.15
1.6 (0.28%)
BSENSE

Sep 23, 02:21 PM

BSE+NSE Vol: 8.55 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

8.55 k (-68.23%) Volume

Shareholding (Jun 2026)

FII

1.21%

Held by 16 FIIs

DII

5.21%

Held by 7 DIIs

Promoter

88.98%

Which are the latest news on Ventive Hospital?

23-Sep-2026

Why is Ventive Hospitality Ltd falling/rising?

06-Sep-2026

As of 05-Sep, Ventive Hospitality Ltd's stock price is rising to 588.75, driven by strong investor interest and recent gains despite a year-to-date decline of 22.59%. The stock shows potential value with significant profit growth, but faces challenges such as low management efficiency and pledged shares.

As of 05-Sep, Ventive Hospitality Ltd's stock price is rising, currently at 588.75, with a change of 1.8 (0.31%) upward. This increase can be attributed to several factors. Firstly, the stock has outperformed its sector by 1.47% today and has been on a consecutive gain for the last two days, accumulating a total return of 1.61% during this period. Additionally, there has been a significant increase in investor participation, with delivery volume rising by 877.2% against the 5-day average, indicating heightened interest in the stock.<BR><BR>Despite the stock's year-to-date decline of 22.59% and a one-year return of -20.27%, the company has shown healthy long-term growth, with net sales increasing at an annual rate of 126.90% and operating profit at 80.31%. Furthermore, the stock's PEG ratio of 0.1 suggests that, despite recent poor performance, the company's profits have risen by 248% over the past year, which may attract investors looking for value.<BR><BR>However, it is important to note that the stock's performance is still below its longer-term moving averages, and there are concerns regarding management efficiency, as indicated by a low return on capital employed (ROCE) of 8.62%. Additionally, 36.36% of promoter shares are pledged, which could exert downward pressure in a falling market. Overall, while the stock is currently rising, it faces challenges that could impact its future performance.

View full answer

What does Ventive Hospital do?

01-Sep-2026

Ventive Hospitality Ltd operates in the Hotels & Resorts industry as a Small Cap company, reporting net sales of 543 Cr and a net profit of 81 Cr for June 2026. It has a market cap of INR 13,779 Cr and a P/E ratio of 28.00.

Overview: <BR>Ventive Hospitality Ltd operates in the Hotels & Resorts industry and is categorized as a Small Cap company.<BR><BR>History: <BR>The company was incorporated in 2002 and underwent a status change from Private Limited to Public Limited on August 28, 2024. The most recent quarterly results reported net sales and net profit for June 2026.<BR><BR>Financial Snapshot: <BR>Net Sales: 543 Cr (Quarterly Results - Jun 2026) <BR>Net Profit: 81 Cr (Quarterly Results - Jun 2026) <BR>Market Cap: INR 13,779 Cr (Small Cap)<BR><BR>Key Metrics: <BR>P/E: 28.00 <BR>Industry P/E: 36 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: 0.38 <BR>Return on Equity: 7.84% <BR>Price to Book: 2.48 <BR><BR>Contact Details: <BR>Registrar Address: Not available. <BR>Phone: N/A <BR>Email: N/A <BR>Website: N/A

View full answer

Who are the peers of the Ventive Hospital?

01-Sep-2026

Ventive Hospital's peers include Indian Hotels Co, ITC Hotels, Chalet Hotels, and others, with varying management risks and growth rates. Its 1-year return is -16.33%, better than ITC Hotels but worse than Leela Palaces Ho, which has the highest return at 43.21%.

Peers: The peers of Ventive Hospital are Indian Hotels Co, ITC Hotels, Chalet Hotels, Leela Palaces Ho, EIH, Lemon Tree Hotel, I T D C, Juniper Hotels, Mahindra Holiday, and Samhi Hotels.<BR><BR>Quality Snapshot: Excellent management risk is observed at Indian Hotels Co and EIH, while Good management risk is found at Lemon Tree Hotel. Average management risk is present at ITC Hotels, I T D C, and Juniper Hotels, while Below Average management risk is seen at Chalet Hotels, Leela Palaces Ho, Ventive Hospital, Mahindra Holiday, and Samhi Hotels. Growth is Excellent at Indian Hotels Co, EIH, Chalet Hotels, Lemon Tree Hotel, and Ventive Hospital, while Average growth is found at Leela Palaces Ho, and Below Average growth is observed at ITC Hotels and Juniper Hotels. Capital Structure is Excellent at Indian Hotels Co, ITC Hotels, and EIH, Average at Ventive Hospital and Leela Palaces Ho, and Below Average at Chalet Hotels, Lemon Tree Hotel, I T D C, Juniper Hotels, Mahindra Holiday, and Samhi Hotels.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Leela Palaces Ho at 43.21%, while the lowest is ITC Hotels at -32.71%. Ventive Hospital's 1-year return is -16.33%, which is higher than ITC Hotels but lower than Leela Palaces Ho. Additionally, EIH, Lemon Tree Hotel, Mahindra Holiday, and Samhi Hotels all have negative six-month returns.

View full answer

How big is Ventive Hospital?

01-Sep-2026

As of 31st August, Ventive Hospitality Ltd has a market capitalization of 13,779.00 Cr, with recent net sales of 2,496.42 Cr and a net profit of 479.47 Cr. Shareholder's funds are 5,506.07 Cr, and total assets amount to 10,679.69 Cr as of March 2026.

As of 31st August, Ventive Hospitality Ltd has a market capitalization of 13,779.00 Cr, categorizing it as a Small Cap company.<BR><BR>In the latest four quarters, Ventive Hospitality Ltd reported Net Sales of 2,496.42 Cr and a Net Profit of 479.47 Cr.<BR><BR>The latest reporting period for the balance sheet is March 2026, with Shareholder's Funds amounting to 5,506.07 Cr and Total Assets of 10,679.69 Cr.

View full answer

Should I buy, sell or hold Ventive Hospitality Ltd?

06-Aug-2026

Are Ventive Hospitality Ltd latest results good or bad?

05-Aug-2026

Ventive Hospitality Ltd's latest Q1 FY27 results show a concerning decline, with a 64.82% drop in net profit quarter-on-quarter and a 30.30% decrease in revenue, despite year-on-year growth. The significant margin pressures indicate operational challenges that need to be addressed.

Ventive Hospitality Ltd's latest results for Q1 FY27 indicate a challenging period for the company. The consolidated net profit of ₹80.75 crore reflects a significant decline of 64.82% compared to the previous quarter, although it shows a remarkable increase of 199.85% year-on-year. Revenue also fell sharply by 30.30% quarter-on-quarter to ₹542.80 crore, despite a modest year-on-year growth of 6.97%. <BR><BR>The operating margin has decreased to 35.56%, marking the lowest efficiency in seven quarters, and the PAT margin has contracted dramatically to 4.04%. These figures highlight the company's struggle to maintain profitability during the off-peak season, which is typical for the hospitality industry but has been exacerbated in this case.<BR><BR>Overall, while there are some positive year-on-year comparisons, the sharp declines in key metrics quarter-on-quarter suggest that the latest results are more concerning than encouraging. The operational challenges and margin pressures indicate a need for careful monitoring and potential strategic adjustments moving forward.

View full answer

When is the next results date for Ventive Hospitality Ltd?

28-Jul-2026

The next results date for Ventive Hospitality Ltd is August 4, 2026.

The next results date for Ventive Hospitality Ltd is scheduled for August 4, 2026.

View full answer

How has been the historical performance of Ventive Hospital?

13-Nov-2025

Ventive Hospital experienced significant financial growth from March 2024 to March 2025, with net sales increasing to 1,604.71 Cr from 477.98 Cr, and operating profit rising to 828.65 Cr. However, profit after tax slightly decreased to 181.03 Cr, and earnings per share dropped to 5.15 due to changes in equity capital.

Answer:<BR>The historical performance of Ventive Hospital shows significant growth in various financial metrics from March 2024 to March 2025.<BR><BR>Breakdown:<BR>In the fiscal year ending March 2025, Ventive Hospital reported net sales of 1,604.71 Cr, a substantial increase from 477.98 Cr in the previous year. Total operating income mirrored this growth, reaching 1,604.71 Cr compared to 477.98 Cr in March 2024. The total expenditure, excluding depreciation, rose to 843.88 Cr from 194.15 Cr, driven by higher raw material costs and employee expenses. Operating profit (PBDIT) also saw a notable rise to 828.65 Cr from 300.56 Cr, despite an increase in interest expenses to 256.69 Cr from 47.22 Cr. Profit before tax increased to 309.65 Cr from 205.19 Cr, while profit after tax slightly decreased to 181.03 Cr from 166.32 Cr, leading to a consolidated net profit of 120.29 Cr compared to 166.32 Cr in the prior year. The earnings per share (EPS) dropped significantly to 5.15 from 159.31, reflecting changes in equity capital, which rose to 23.35 Cr from 10.44 Cr. On the balance sheet, total liabilities stood at 9,841.36 Cr, with total assets also matching this figure, indicating a balanced position. The cash flow from operating activities was 677.00 Cr, while cash flow from investing activities showed an outflow of 1,661.00 Cr, and financing activities contributed an inflow of 1,363.00 Cr, resulting in a net cash inflow of 379.00 Cr, increasing the closing cash and cash equivalents to 412.00 Cr.

View full answer

Is Ventive Hospital overvalued or undervalued?

09-Jun-2025

As of February 14, 2025, Ventive Hospital is considered very expensive and overvalued with a PE ratio of 141.20, significantly higher than its peers, and has underperformed the Sensex with a recent stock return of -1.53%.

As of 14 February 2025, Ventive Hospital's valuation grade has moved from does not qualify to very expensive, indicating a significant shift in its perceived market value. The company is currently overvalued, with a PE ratio of 141.20, an EV to EBITDA of 25.91, and a Price to Book Value of 3.64, all of which are substantially higher than industry norms. <BR><BR>In comparison to its peers, Ventive Hospital's PE ratio is notably higher than Indian Hotels Co. Ltd., which stands at 66.81, and ITC Hotels, at 65.26, both of which are also categorized as very expensive. The company's return performance has lagged behind the Sensex recently, with a 1-week stock return of -1.53% compared to a 1.36% gain in the Sensex, reinforcing the view that Ventive Hospital is currently overvalued in the market.

View full answer

What is the technical trend for Ventive Hospital?

09-Jun-2025

As of March 10, 2025, Ventive Hospital's trend is mildly bullish, supported by positive On-Balance Volume and a recent monthly gain, despite a slight weekly decline and current price below the previous close.

As of 10 March 2025, the technical trend for Ventive Hospital has changed to mildly bullish. The weekly Dow Theory indicates a mildly bullish stance, while the On-Balance Volume (OBV) is bullish on a weekly basis. Despite a recent decline of 2.11% over the past week, the stock has shown a positive return of 1.25% over the last month, suggesting some resilience. The current price is 747.00, which is below the previous close of 748.90, but today's high of 762.25 indicates potential upward movement. Overall, the indicators suggest a mildly bullish sentiment, though caution is warranted given the recent price action.

View full answer

Who are the top shareholders of the Ventive Hospital?

06-Jun-2025

The top shareholder of Ventive Hospital is Premsagar Infra Realty Private Limited, holding 37.28% of shares. Other significant shareholders include mutual funds with 5.2%, foreign institutional investors at 2.92%, and individual investors at 2.08%.

The top shareholders of Ventive Hospital include a mix of promoters, mutual funds, and foreign institutional investors. The majority shareholder is Premsagar Infra Realty Private Limited, which holds 37.28% of the shares. Additionally, the promoters collectively have a pledged holding of 7.6993%. <BR><BR>In terms of institutional investors, mutual funds hold 5.2% of the shares through 8 different schemes, while 23 foreign institutional investors (FIIs) collectively own 2.92%. The highest public shareholder is Quant Mutual Fund-Quant ELSS Tax Saver Fund, which has a holding of 4.97%. Individual investors account for 2.08% of the total shareholding.

View full answer

Has Ventive Hospital declared dividend?

06-Jun-2025

No Dividend History Available

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

Poor Management Efficiency with a low ROCE of 8.62%

  • The company has been able to generate a Return on Capital Employed (avg) of 8.62% signifying low profitability per unit of total capital (equity and debt)
2

Flat results in Jun 26

3

36.36% of Promoter Shares are Pledged

4

Below par performance in long term as well as near term

stock-summaryMojo Parameters

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

stock-summary
Industry

Hotels & Resorts

stock-summary
Market cap

INR 13,526 Cr (Small Cap)

stock-summary
P/E

28.00

stock-summary
Industry P/E

36

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.38

stock-summary
Return on Equity

7.84%

stock-summary
Price to Book

2.45

Revenue and Profits:
Net Sales:
543 Cr
(Quarterly Results - Jun 2026)
Net Profit:
81 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-10.16%
0%
-10.16%
6 Months
-7.59%
0%
-7.59%
1 Year
-24.76%
0%
-24.76%
2 Years
0%
0%
0.0%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%

Ventive Hospital for the last several years.

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions

Announcements stock-summary

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

05-Sep-2026 | Source : BSE

Intimation about participation in the Investors Conference.

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

27-Aug-2026 | Source : BSE

Update on Schedule of Investor Conference.

Shareholder Meeting / Postal Ballot-Outcome of AGM

26-Aug-2026 | Source : BSE

Proceedings of 25th Annual General Meeting of the Company held on Wednesday August 26 2026

Corporate Actions stock-summary

stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
126.90%
EBIT Growth (5y)
80.31%
EBIT to Interest (avg)
2.62
Debt to EBITDA (avg)
2.75
Net Debt to Equity (avg)
0.38
Sales to Capital Employed (avg)
0.33
Tax Ratio
32.05%
Dividend Payout Ratio
0
Pledged Shares
36.36%
Institutional Holding
6.42%
ROCE (avg)
16.33%
ROE (avg)
5.20%

Valuation key factors

Factor
Value
P/E Ratio
28
Industry P/E
36
Price to Book Value
2.45
EV to EBIT
21.01
EV to EBITDA
14.44
EV to Capital Employed
2.04
EV to Sales
6.24
PEG Ratio
0.11
Dividend Yield
NA
ROCE (Latest)
10.05%
ROE (Latest)
7.84%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Dow Theory
No Trend
Mildly Bearish
OBV
Mildly Bearish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Jun 2026stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

36.3648

Mutual Funds

Held by 4 Schemes (5.21%)

FIIs

Held by 16 FIIs (1.21%)

Promoter with highest holding

Premsagar Infra Realty Private Limited (37.28%)

Highest Public shareholder

Quant Mutual Fund-quant Elss Tax Saver Fund (4.99%)

Individual Investors Holdings

2.54%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2026 is -30.30% vs 13.61% in Mar 2026",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2026 is -64.82% vs 96.84% in Mar 2026",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'26",
        "Mar'26",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "542.80",
          "val2": "778.79",
          "chgp": "-30.30%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "193.03",
          "val2": "385.25",
          "chgp": "-49.89%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "52.21",
          "val2": "53.39",
          "chgp": "-2.21%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-5.09",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "80.75",
          "val2": "229.54",
          "chgp": "-64.82%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "35.56%",
          "val2": "49.47%",
          "chgp": "-13.91%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "290.19",
          "val2": "243.76",
          "chgp": "19.05%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "143.19",
          "val2": "134.76",
          "chgp": "6.26%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "36.63",
          "val2": "41.03",
          "chgp": "-10.72%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "104.05",
          "val2": "47.15",
          "chgp": "120.68%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "49.34%",
          "val2": "55.28%",
          "chgp": "-5.94%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2025 is 16.07% vs 40.31% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2025 is 108.40% vs 27.46% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "463.51",
          "val2": "399.34",
          "chgp": "16.07%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "226.67",
          "val2": "218.53",
          "chgp": "3.72%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "55.49",
          "val2": "78.02",
          "chgp": "-28.88%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-2.00",
          "val2": "-6.11",
          "chgp": "67.27%",
          "chgp_class": "positive"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "159.51",
          "val2": "76.54",
          "chgp": "108.40%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "48.90%",
          "val2": "54.72%",
          "chgp": "-5.82%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2026 is 53.36% vs 235.73% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2026 is 253.85% vs -27.68% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "2,461.05",
          "val2": "1,604.71",
          "chgp": "53.36%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1,093.65",
          "val2": "760.83",
          "chgp": "43.74%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "229.49",
          "val2": "256.69",
          "chgp": "-10.60%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-8.09",
          "val2": "-6.11",
          "chgp": "-32.41%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "425.65",
          "val2": "120.29",
          "chgp": "253.85%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "44.44%",
          "val2": "47.41%",
          "chgp": "-2.97%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'26 - QoQstock-summary

Jun'26
Mar'26
Change(%)
Net Sales
542.80
778.79
-30.30%
Operating Profit (PBDIT) excl Other Income
193.03
385.25
-49.89%
Interest
52.21
53.39
-2.21%
Exceptional Items
0.00
-5.09
100.00%
Consolidate Net Profit
80.75
229.54
-64.82%
Operating Profit Margin (Excl OI)
35.56%
49.47%
-13.91%
Values in Rs Cr.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Jun 2026 is -30.30% vs 13.61% in Mar 2026

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Jun 2026 is -64.82% vs 96.84% in Mar 2026

Half Yearly Results Snapshot (Standalone) - Sep'25stock-summary

Sep'25
Sep'24
Change(%)
Net Sales
290.19
243.76
19.05%
Operating Profit (PBDIT) excl Other Income
143.19
134.76
6.26%
Interest
36.63
41.03
-10.72%
Exceptional Items
0.00
0.00
Standalone Net Profit
104.05
47.15
120.68%
Operating Profit Margin (Excl OI)
49.34%
55.28%
-5.94%
Values in Rs Cr.
Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

Nine Monthly Results Snapshot (Standalone) - Dec'25stock-summary

Dec'25
Dec'24
Change(%)
Net Sales
463.51
399.34
16.07%
Operating Profit (PBDIT) excl Other Income
226.67
218.53
3.72%
Interest
55.49
78.02
-28.88%
Exceptional Items
-2.00
-6.11
67.27%
Standalone Net Profit
159.51
76.54
108.40%
Operating Profit Margin (Excl OI)
48.90%
54.72%
-5.82%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2025 is 16.07% vs 40.31% in Dec 2024

Direction Arrows
Standalone Net Profit

YoY Growth in nine months ended Dec 2025 is 108.40% vs 27.46% in Dec 2024

Annual Results Snapshot (Consolidated) - Mar'26stock-summary

Mar'26
Mar'25
Change(%)
Net Sales
2,461.05
1,604.71
53.36%
Operating Profit (PBDIT) excl Other Income
1,093.65
760.83
43.74%
Interest
229.49
256.69
-10.60%
Exceptional Items
-8.09
-6.11
-32.41%
Consolidate Net Profit
425.65
120.29
253.85%
Operating Profit Margin (Excl OI)
44.44%
47.41%
-2.97%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2026 is 53.36% vs 235.73% in Mar 2025

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2026 is 253.85% vs -27.68% in Mar 2025

stock-summaryCompany CV
About Ventive Hospitality Ltd stock-summary
stock-summary
Ventive Hospitality Ltd
Small Cap
Hotels & Resorts
Ventive Hospitality Limited (Formerly known as ICC Realty (India) Private Limited) was incorporated as a Private Limited Company on February 12, 2002. The status of the Company got converted from Private Limited to Public Limited and the name of the Company has changed to Ventive Hospitality Limited at Registrar of Companies, Pune on August 28, 2024.
Company Coordinates stock-summary
Icon
No Company Details Available